HCPCS Code A9607: Lutetium Lu 177 Vipivotide Tetraxetan, Therapeutic, 1 millicurie

HCPCS Code A9607: Lutetium Lu 177 Vipivotide Tetraxetan, Therapeutic, 1 millicurie

Read our guide on HCPCS Code A9607 for billing Lutetium Lu 177 vipivotide tetraxetan (Pluvicto), a therapeutic radioligand for PSMA-positive prostate cancer, billed per 1 mCi.

Use Code

Frequently asked questions

Each one mCi equals one billing unit. For a 200 mCi dose, you would submit 200 units of A9607.

Use JZ if no drug amount is discarded and JW if any portion is discarded. Modifier UD is used for 340B-purchased drugs in Medicaid PADP contexts.

Yes—Pluvicto has transitional pass-through status under OPPS (status indicator “G”) through September 30, 2025, allowing separate outpatient payment.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments